Abstract:e13592 Background: Fibroblast activation protein (FAP), a transmembrane serine peptidase, is expressed by tumor-associated fibroblasts. As an important factor in tumor microenvironment, it has been reported that FAP plays a dual role in tumor progression, both positive and negative. In a mouse model of breast cancer, FAP increasing microvessel densities had been experimentally demonstrated. The aim of the study was to determine the effect of FAP in tumor growth and tumor microenvironment in LLC mouse models, especially in lung metastasis model. Methods: Female C57 mice received i.v injection of LLC cells into tail vein or s.c into right flank to establish lung metastasis model or subcutaneous xenograft model. 21 mice were randomly divided into 3 groups (n=7, per group) and treated with 5% GS,control-shRNA or FAP-shRNA, respectively. Xenograft tumor size and weight, numbers of pulmonary metastatic nodules and lung weight were measured. FAP expression, microvessel density and collagen fiber were evaluated. Data were analyzed using one-way analysis of variance (ANOVA), and a value of P <0.05 was considered to be statistically significant. Results: FAP-shRNA decreased significantly in the number of metastases on the lung surface and average lung weight, compared with 5%GS and control-shRNA (P<0.05).The size of metastases in treatment group was large than those of the controls (P<0.05). Moreover, FAP-shRNA showed a significant reduction of 44% in tumor volume and tumor weight, relative to other groups (P<0.05). In both models, FAP expression and microvessel density were lower in treatment group compared to the controls. And FAP-shRNA indicated an increase in the accumulation of collagen fiber. Conclusions: The study suggests that shRNA targeting FAP inhabit tumor growth in LLC mouse models, especially in lung metastasis model. We hypothesize that the anti-tumor mechanism is related to angiogenesis reduction and alteration of collage fibro accumulation, which eventually change tumor microenvironment. These findings indicate the potential of FAP as a new therapeutic strategy for lung cancer.

Suppression of Human MDA-MB-435S Tumor by U6 Promoter-Driven Short Hairpin RNAs Targeting Focal Adhesion Kinase

Rna Interference-Mediated Silencing Of Focal Adhesion Kinase Inhibits Growth Of Human Colon Carcinoma Xenograft In Nude Mice

RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.

[RNA Interference Targeting Focal Adhesion Kinase Inhibited the Growth of Human Hepatocellular Carcinoma Sk-Hep-1].

RNA interference targeting human FAK and EGFR suppresses human non-small-cell lung cancer xenograft growth in nude mice

Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model

Focal Adhesion Kinase Expression: A Potential Tumor Therapy Target

Polyethylenimine-complexed Plasmid Particles Targeting Focal Adhesion Kinase Function As Melanoma Tumor Therapeutics

Effect of Short Hairpin RNA Targeting of Fibroblast Activation Protein on Tumor Growth and Angiogenesis in a 4T1 Murine Breast Cancer Model.

Administration of PLGA Nanoparticles Carrying Shrna Against Focal Adhesion Kinase and CD44 Results in Enhanced Antitumor Effects Against Ovarian Cancer

The effect of silenced focal adhesion kinase on colorectal cancer metastasis in vivo

Efficient inhibition of non-small-cell lung cancer xenograft by systemic delivery of plasmid-encoding short-hairpin RNA targeting VEGF.

The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis

Interference effects of short-hairpin RNA on focal adhesion kinase on the sensitivity to 5-fluorouracil of multicellular spheroids of colonic carcinoma

Suppression of Tumor Progression and Angiogenesis in Two Lewis Lung Carcinoma Mouse Models by Shrna Knockdown of Fibroblast Activation Protein.

Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP

The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.

Suppression of C-Flipl Promotes Jnk Activation in Malignant Melanoma Cells

Effective Suppression of the Kirsten Rat Sarcoma Viral Oncogene in Pancreatic Tumor Cells Via Targeted Small Interfering RNA Delivery Using Nanoparticles

Targeted delivery of PLK1-siRNA by ScFv suppresses Her2 + breast cancer growth and metastasis

Antisense Oligonucleodes Targeting the Focal Adhesion Kinase Inhibit Proliferation, Induce Apoptosis and Cooperate with Cytotoxic Drugs in Human Glioma Cells